Levi & Korsinsky Reminds Tenax Therapeutics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 28, 2026 - TENX

By ACCESS Newswire

NEW YORK CITY, NY / ACCESS Newswire / November 13, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Tenax Therapeutics, Inc. (NASDAQ:TENX) securities.

If you purchased NASDAQ:TENX securities and suffered a loss, Learn about Tenax Therapeutics, Inc. Class Action or call (212)363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: A class action securities lawsuit was filed against Tenax Therapeutics, Inc. that seeks to recover losses of Tenax Therapeutics, Inc. shareholders who were adversely affected by alleged securities fraud between November 13, 2023 and August 7, 2026.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) the Company's lead clinical program, TNX-103 was less effective than defendants had led investors to believe; (ii) accordingly, TNX-103's overall clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

WHAT'S NEXT? If you purchased Tenax Therapeutics, Inc. securities during the relevant time frame, learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured billions of dollars for aggrieved shareholders. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212)363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE: Levi & Korsinsky, LLP



View the original press release on ACCESS Newswire

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.